Interventional bronchoscopy in lung cancer treatment

Data de publicação:

Unidades de investigação

Abstract

Interventional bronchoscopy has seen significant advancements in recent decades, particularly in the context of lung cancer. This method has expanded not only diagnostic capabilities but also therapeutic options. In this article, we will outline various therapeutic approaches employed through either a rigid or flexible bronchoscope in multimodal lung cancer treatment. A pivotal focus lies in addressing central airway obstruction resulting from cancer. We will delve into the treatment of initial malignant changes in central airways and explore the rapidly evolving domain of early peripheral malignant lesions, increasingly discovered incidentally or through lung cancer screening programmes. A successful interventional bronchoscopic procedure not only alleviates severe symptoms but also enhances the patient's functional status, paving the way for subsequent multimodal treatments and thereby extending the possibilities for survival. Interventional bronchoscopy proves effective in treating initial cancerous changes in patients unsuitable for surgical or other aggressive treatments due to accompanying diseases. The key advantage of interventional bronchoscopy lies in its minimal invasiveness, effectiveness and favourable safety profile.

Dados da publicação

ISSN/ISSNe:
1810-6838, 2073-4735

Breathe  European Respiratory Society

Tipo:
Article
Páginas:
-

Citações Recebidas na Web of Science: 1

Documentos

  • Não há documentos

Métricas

Filiações

Filiações não disponíveis

Keywords

  • CENTRAL AIRWAY-OBSTRUCTION; QUALITY-OF-LIFE; MALIGNANT ENDOBRONCHIAL TUMORS; DOSE-RATE BRACHYTHERAPY; PHOTODYNAMIC THERAPY; RESPIRATORY-FAILURE; FOLLOW-UP; INTRATUMORAL CHEMOTHERAPY; RIGID BRONCHOSCOPY; AMERICAN-COLLEGE

Proyectos asociados

Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG) -NCT05635032

Investigador Principal: Hélder Novais e Bastos

Estudo Observacional Académico (FIBRALUNG) . FCT . 2021

MCP1 as a prognostic biomarker in Hypersensitivity Pneumonitis: a prospective study

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico (Pneumonitis) . 2023

Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2020

Impact of Chronic Obstructive Pulmonary Disease in surgical outcomes of lung cancer patients undergoing curative intent surgery

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2021

Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2021

Non-invasive assessment of Benign Tracheal Stenosis.

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2020

Predictors of lung entrapment in malignant pleural effusion

Investigador Principal: Hélder Novais e Bastos

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação